Janssen Biotech was granted a patent for manufacturing anti-IL-12/IL-23 antibodies

{
  "signal_id": "35dde10b-1810-5e42-83c1-c655c3959d5c",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-09-30T16:58:53+00:00",
  "company": {
    "name": "Johnson & Johnson",
    "domain": "jnj.com"
  },
  "data": {
    "cpc": [
      {
        "code": "C07K 16/244"
      },
      {
        "code": "C07K 1/18"
      },
      {
        "code": "C07K 2317/14"
      },
      {
        "code": "C07K 2317/31"
      },
      {
        "code": "C12N 5/0682"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Medical Research"
    ],
    "detail": "In September 2026 Janssen Biotech patented methods for producing ustekinumab antibody compositions in CHO cells for pharmaceutical treatments across multiple diseases.",
    "summary": "Janssen Biotech was granted a patent for manufacturing anti-IL-12/IL-23 antibodies",
    "event_at": "2026-09-29",
    "inventors": [
      {
        "name": "Kristopher Barnthouse",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/kristopher-kris-barnthouse-b727653"
      },
      {
        "name": "Subinay Ganguly",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/subinay-ganguly-2477205"
      },
      {
        "name": "Maarten Groeneveld",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/maarten-groeneveld-2a061829"
      },
      {
        "name": "Manuel Lopez, Jr.",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Michael Nedved",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/mike-nedved-4bb6916"
      },
      {
        "name": "Kevin D. Smith",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-09-29",
    "source_url": "https://patents.google.com/patent/US12747289",
    "cpc_primary": {
      "code": "C07K 16/244"
    },
    "patent_title": "Manufacturing methods for producing anti-IL12/IL23 antibody compositions",
    "patent_number": "US12747289",
    "uspto_assignee": "Janssen Biotech, Inc.",
    "patent_abstract": "Methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, in CHO and specific pharmaceutical compositions of the antibody are useful in treating various diseases.",
    "precision_class": "structural",
    "invention_explanation": "A manufacturing process that uses engineered CHO cells to make consistent anti-IL-12/IL-23p40 antibody medicines and formulate them for treatment.",
    "technologies_mentioned": [
      "antibody manufacturing",
      "CHO cell culture",
      "biologics formulation"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/35dde10b-1810-5e42-83c1-c655c3959d5c \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"jnj.com","limit":20}'